Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN51,9752,01-0,57
Msft0,99
Nokia4,20054,37251,02
IBM0,74
Mercedes-Benz Group AG56,0356,050,45
PFE-0,74
02.11.2024 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 01.11.2024 17:30:25
Roche Holding AG (RHHVF.PK, US Other OTC (Pink Sheets))
Závěr k 31.10.2024 Změna (%) Změna (USD) Objem obchodů (ks)
308,09 1,46 4,50 151
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 02.11.2024
Popis společnosti
Obecné informace
Název společnostiRoche Holding AG
TickerROG
TickerRO
Kmenové akcie:Genussscheine
Kmenové akcie:Ordinary Shares
RICRO.S
RICROG.S
ISINCH0012032048
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky30.09.2024
Počet zaměstnanců k 31.12.2023 103 605
Akcie v oběhu k 30.06.2024 796 789 129
MěnaCHF
Kontaktní informace
UliceGrenzacherstrasse 124
MěstoBASEL
PSČ4002
ZeměSwitzerland
Kontatní osobaLoren Kalm
Funkce kontaktní osobyInvestor Relations Officer
Telefon419 732 354 295
Kontatní telefon16 502 253 217

Business Summary: Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Roche Holding AG revenues increased less than 1% to SF29.85B. Net income decreased 12% to SF6.26B. Revenues reflect Europe segment increase of 8% to SF4.43B, United States segment increase of 2% to SF13.8B, also reflect Japan segment decrease of 38% to SF1.37B, Asia-Pacific. segment decrease of 9% to SF829M.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSIn-Vitro Diagnostic Substance Manufacturing
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Biological Product (exc Diagnostic) Mfg
NAICS2007In-Vitro Diagnostic Substance Mfg
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Medicinal & Botanical Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Biological Product (except Diagnostic) Manufacturing
NAICS1997InVitro Diagnostic Substance Manufacturing
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Offices of Other Holding Companies
SICPharmaceutical Preparations
SICBiological Prod's Not Diagnostic
SICDiagnostic Substances
SICAnalytical Instruments
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments
SICMedicinals And Botanicals
SICElectromedical Equipment
SICHolding Companies, Nec



  • Poslední aktualizace: 02.11.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Member of the Corporate Executive CommitteeThomas Schinecker4914.03.202301.08.2019
Member of the Corporate Executive Committee, Chief Financial and Information OfficerAlan Hippe5701.04.201101.04.2011
Member of the Corporate Executive Committee, Chief People OfficerCristina Wilbur57
Chief Compliance OfficerPascale Schmidt5001.01.2020
Member of the Enlarged Corporate Executive Committee, General CounselClaudia Boeckstiegel6001.04.202001.04.2020
Member of the Enlarged Corporate Executive Committee, Head Corporate Strategy and Sustainability, Secretary to the Corporate ExeSilke Hoernstein4901.04.202301.04.2023
Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research and Early Development (pRED)Hans Clevers6718.03.202218.03.2022
Member of the Enlarged Corporate Committee, Head of Global Product Development and Chief Medical OfficerLevi Garraway5601.03.202301.03.2023
Member of the Corporate Executive Committee, Chief Executive Officer of Roche PharmaceuticalsTeresa Graham5101.03.202301.03.2023
Member of the Enlarged Corporate Executive Committee, Head Genentech Research and Early Development (gRED)Aviv Regev5301.01.2020